Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Apidra wins approval for use by children.


Byline: Dubai

(Image: apidra.gif )

European Commission has approved Apidra, a rapid-acting insulin analog for the control of hyperglycemia hyperglycemia: see diabetes.  in adolescents and children with diabetes, Sanofi-aventis has announced.

The approval of Apidra (insulin glulisine insulin glulisine, recombinant

Apidra

Pharmacologic class: Pancreatic hormone

Therapeutic class: Hypoglycemic

Pregnancy risk category B

Action

 [rDNA origin] injection) for paediatric Adj. 1. paediatric - of or relating to the medical care of children; "pediatric dentist"
pediatric
 use provides children (6 years and older) with the option of using Apidra as part of their overall diabetes treatment plan, usually in combination with a basal insulin, it said.

The approval is based upon review of a 26-week, phase III, open-label, active control study of Apidra in comparison with Humalog (both administered pre-meal) in 572 children and adolescents with Type 1 diabetes type 1 diabetes
n.
See diabetes mellitus.
.

eIuSanofi-aventis recognises the many challenges faced by children with diabetes and their families, and is committed to providing pediatric patients and their healthcare providers with new treatment options,eIN said Dr Riccardo Perfetti, senior medical director, Diabetes-Metabolism Franchise, Sanofi-aventis. eIuWith the rapid-acting APIDRAE1/2 insulin analog, we hope to offer patients an effective treatment of choice for their overall diabetes therapy.eIN

Dr Hisham Mahmoud, medical director of Sanofi-aventis Gulf, said: eIuNo less than five GCC GCC: see Gulf Cooperation Council.

(compiler, programming) GCC - The GNU Compiler Collection, which currently contains front ends for C, C++, Objective-C, Fortran, Java, and Ada, as well as libraries for these languages (libstdc++, libgcj, etc).
 countries rank their current diabetes prevalence among the worldeIUs 10 highest, including the UAE (Uninterruptible Application Error) The name given to a crash in Windows 3.0. In subsequent versions of Windows, a crash was called a "General Protection Fault," "Application Error" or "Illegal Operation." See crash in Windows and abend. , where overall prevalence of the disease is estimated at over 20 per cent. This clearly indicates the need for effective new measures to tackle the threat of diabetes, especially among children, since there has been a dramatic rise in juvenile diabetes cases across the Gulf region.eIN

Apidra works fast and offers flexible insulin dosing to help manage mealtime blood sugar levels, and should be administered shortly (0-15 min) before or soon after the meal, he said.

Apidra has a rapid onset and short duration of action which allows covering the postprandial postprandial /post·pran·di·al/ (-pran´de-al) occurring after a meal.

post·pran·di·al
adj.
Following a meal, especially dinner.
 hyperglycemic hyperglycemic /hy·per·gly·ce·mic/ (-gli-se´mik)
1. pertaining to, characterized by, or causing hyperglycemia.

2. an agent that increases the glucose level of the blood.
 peaks. It should normally be used in combination with a long-acting or basal insulin to cover the fasting and interprandial hyperglycemia. Apidra can also be used alone in insulin infusion pump therapy for blood sugar control, the statement said. eI TradeArabia News Service

E Copyright 2007 www.tradearabia.com

Copyright 2008 Al Hilal Publishing & Marketing Group

Provided by Syndigate.info an Albawaba.com company
COPYRIGHT 2008 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:TradeArabia (Manama, Bahrain)
Date:Aug 13, 2008
Words:349
Previous Article:Major trial run held at Dubai Terminal 3.
Next Article:Smart Tech announces new solutions.
Topics:

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles